|
EPS15L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.776300E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.86960000000602E-05 |
| Normal-vs-Stage2 |
4.826200E-01 |
| Normal-vs-Stage3 |
1.893670E-02 |
| Normal-vs-Stage4 |
4.850200E-01 |
| Stage1-vs-Stage2 |
8.235900E-02 |
| Stage1-vs-Stage3 |
6.19750029073884E-10 |
| Stage1-vs-Stage4 |
4.965600E-04 |
| Stage2-vs-Stage3 |
3.813700E-02 |
| Stage2-vs-Stage4 |
2.830600E-01 |
| Stage3-vs-Stage4 |
3.918000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.048800E-01 |
| Normal-vs-AfricanAmerican |
1.249750E-02 |
| Normal-vs-Asian |
6.529500E-02 |
| Caucasian-vs-AfricanAmerican |
2.343700E-02 |
| Caucasian-vs-Asian |
2.283900E-03 |
| AfricanAmerican-vs-Asian |
3.552600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.272400E-01 |
| Normal-vs-Female |
1.655710E-03 |
| Male-vs-Female |
1.444750E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.727600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.497520E-02 |
| Normal-vs-Age(61-80Yrs) |
5.299000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.883200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.752800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.786000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.824200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.939700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.428100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.012000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.399600E-03 |
| Normal-vs-Grade 2 |
2.256600E-03 |
| Normal-vs-Grade 3 |
8.077600E-01 |
| Normal-vs-Grade 4 |
5.786000E-02 |
| Grade 1-vs-Grade 2 |
1.060140E-03 |
| Grade 1-vs-Grade 3 |
8.2475999999998E-05 |
| Grade 1-vs-Grade 4 |
1.396360E-03 |
| Grade 2-vs-Grade 3 |
9.678000E-03 |
| Grade 2-vs-Grade 4 |
2.39260000000074E-05 |
| Grade 3-vs-Grade 4 |
4.703800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.64030000000227E-05 |
| Normal-vs-ccB subtype |
6.524000E-01 |
| ccA subtype-vs-ccB subtype |
1.951930E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.367200E-01 |
| Normal-vs-N1 |
8.712200E-01 |
| N0-vs-N1 |
9.829600E-01 |
|
|
